Comparative Evaluation of Vitek 2 and Etest versus Broth Microdilution for Ceftazidime/Avibactam and Ceftolozane/Tazobactam Susceptibility Testing of
BMD
antimicrobial susceptibility testing
carbapenem-resistant Enterobacterales
carbapenem-resistant Pseudomonas
challenge isolates
major error
very major error
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
27 Jun 2022
27 Jun 2022
Historique:
received:
17
05
2022
revised:
16
06
2022
accepted:
24
06
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Ceftazidime/avibactam (CZA) and ceftolozane/tazobactam (C/T) are novel antibiotics with activity against multidrug-resistant Gram-negative pathogens. Nevertheless, resistance to both agents has been reported emphasizing the need for accurate and widely accessible susceptibility testing. In the present study, Vitek 2 and Etest CAZ and C/T MIC results for 100 non-repetitive clinical isolates (83
Identifiants
pubmed: 35884118
pii: antibiotics11070865
doi: 10.3390/antibiotics11070865
pmc: PMC9312067
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Front Microbiol. 2021 Sep 16;12:710526
pubmed: 34603236
Drugs. 2018 Apr;78(6):675-692
pubmed: 29671219
Clin Infect Dis. 2016 Jul 1;63(1):83-8
pubmed: 27025822
Lancet. 2022 Feb 12;399(10325):629-655
pubmed: 35065702
Infection. 2018 Apr;46(2):165-181
pubmed: 29110143
J Antimicrob Chemother. 2018 Apr 1;73(4):909-915
pubmed: 29365094
Antibiotics (Basel). 2021 Apr 10;10(4):
pubmed: 33920199
Med Sci (Basel). 2017 Dec 21;6(1):
pubmed: 29267233
J Clin Med. 2021 Mar 04;10(5):
pubmed: 33806604
Nat Rev Microbiol. 2019 Jan;17(1):3
pubmed: 30467331
Clin Infect Dis. 2017 Jul 1;65(1):158-161
pubmed: 28329350
Int J Antimicrob Agents. 2019 Apr;53(4):408-415
pubmed: 30415002
Infect Dis Clin North Am. 2020 Dec;34(4):773-819
pubmed: 33011051
J Antimicrob Chemother. 2021 Sep 15;76(10):2586-2592
pubmed: 34245282
JAC Antimicrob Resist. 2021 Jul 16;3(3):dlab092
pubmed: 34286272
J Clin Microbiol. 2018 Aug 27;56(9):
pubmed: 29976590
J Clin Microbiol. 2018 Jan 24;56(2):
pubmed: 29167294
J Clin Microbiol. 2018 Aug 27;56(9):
pubmed: 29899002
Int J Antimicrob Agents. 2019 Aug;54(2):255-260
pubmed: 31071465
J Clin Microbiol. 2021 Feb 18;59(3):
pubmed: 33268536
Lancet Infect Dis. 2018 Mar;18(3):318-327
pubmed: 29276051
Euro Surveill. 2018 Nov;23(46):
pubmed: 30458912
Infect Dis Ther. 2021 Dec;10(4):1989-2034
pubmed: 34379310
J Clin Microbiol. 2018 Feb 22;56(3):
pubmed: 29212704
Front Med (Lausanne). 2019 Apr 16;6:74
pubmed: 31041313
Lancet Infect Dis. 2019 Dec;19(12):1299-1311
pubmed: 31563344
BMC Microbiol. 2020 Jun 29;20(1):187
pubmed: 32600252